227 related articles for article (PubMed ID: 31814295)
21. Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.
Zhao S; Ma D; Xiao Y; Jiang YZ; Shao ZM
Eur J Surg Oncol; 2018 Apr; 44(4):420-428. PubMed ID: 29429597
[TBL] [Abstract][Full Text] [Related]
22. Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis.
Sanges F; Floris M; Cossu-Rocca P; Muroni MR; Pira G; Urru SAM; Barrocu R; Gallus S; Bosetti C; D'Incalci M; Manca A; Uras MG; Medda R; Sollai E; Murgia A; Palmas D; Atzori F; Zinellu A; Cambosu F; Moi T; Ghiani M; Marras V; Santona MC; Canu L; Valle E; Sarobba MG; Onnis D; Asunis A; Cossu S; OrrĂ¹ S; De Miglio MR
BMC Cancer; 2020 Jun; 20(1):491. PubMed ID: 32487046
[TBL] [Abstract][Full Text] [Related]
23. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
[TBL] [Abstract][Full Text] [Related]
24. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment.
Berman AT; Thukral AD; Hwang WT; Solin LJ; Vapiwala N
Clin Breast Cancer; 2013 Apr; 13(2):88-94. PubMed ID: 23218473
[TBL] [Abstract][Full Text] [Related]
25. How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data.
Dong F; Fu H; Shi X; Shen Y; Xu T; Gao F; Wang X; Zhong S; Ding Q; Shen Z; Chen S
Clin Exp Metastasis; 2017 Dec; 34(8):467-477. PubMed ID: 29500709
[TBL] [Abstract][Full Text] [Related]
26. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract][Full Text] [Related]
27. Distant metastasis in triple-negative breast cancer.
Tseng LM; Hsu NC; Chen SC; Lu YS; Lin CH; Chang DY; Li H; Lin YC; Chang HK; Chao TC; Ouyang F; Hou MF
Neoplasma; 2013; 60(3):290-4. PubMed ID: 23373998
[TBL] [Abstract][Full Text] [Related]
28. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
29. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
Li H; Chen Y; Wang X; Tang L; Guan X
Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
[TBL] [Abstract][Full Text] [Related]
30. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
31. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.
Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL
Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421
[TBL] [Abstract][Full Text] [Related]
32. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study.
Qiu MZ; Shi SM; Chen ZH; Yu HE; Sheng H; Jin Y; Wang DS; Wang FH; Li YH; Xie D; Zhou ZW; Yang DJ; Xu RH
Cancer Med; 2018 Aug; 7(8):3662-3672. PubMed ID: 29984918
[TBL] [Abstract][Full Text] [Related]
33. Incidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia.
Alcantara VS; Lim GH; Lim SH; Sultana R; Lee JA
J Surg Oncol; 2017 Apr; 115(5):523-537. PubMed ID: 28168712
[TBL] [Abstract][Full Text] [Related]
34. Association between androgen receptor status and prognosis in triple negative breast cancer.
Sunar V; T Dogan H; Sarici F; Ates O; Akin S; Baspinar B; Aksoy S; Altundag K
J BUON; 2018; 23(5):1325-1330. PubMed ID: 30570854
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
[TBL] [Abstract][Full Text] [Related]
37. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
[TBL] [Abstract][Full Text] [Related]
38. Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia.
Anwar SL; Avanti WS; Nugroho AC; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T; Wulaningsih W
World J Surg Oncol; 2020 May; 18(1):117. PubMed ID: 32473643
[TBL] [Abstract][Full Text] [Related]
39. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
40. Distant metastases in newly diagnosed tongue squamous cell carcinoma.
Cai X; Huang J
Oral Dis; 2019 Oct; 25(7):1822-1828. PubMed ID: 31206925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]